Immunohistochemical analysis of dUTPase in human breast adenocarcinoma

Slides:

Advertisements

Similar presentations

Reproduced with permission from Cronin M et al

Advertisements

AZD9291 inhibits EGFR phosphorylation and downstream signaling in murine models of EGFRT790M-resistant lung cancer. AZD9291 inhibits EGFR phosphorylation.

سرطان الثدي Breast Cancer

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Immunohistochemical staining for RXR subtypes within benign and endometrioid endometrial carcinoma. Immunohistochemical staining for RXR subtypes within.

PD-1 and LAG-3 expression in MSI and MSS colorectal cancer specimens.

A, representative gross feature of a gastric cancer (arrows), an ulceroinfiltrative mass in the antral mucosa, arising in Pdx-1-Cre;Smad4F/F;Trp53F/F;Cdh1F/+

Geographic distribution in situ of MSI and MSS colorectal cancer–infiltrating lymphocytes. Geographic distribution in situ of MSI and MSS colorectal cancer–infiltrating.

IHC staining of FFPE esophageal tissues in tissue microarrays (×20).

Effects of SC144 on in vivo ovarian tumor.

Predictive biomarker analyses in cytological specimens

The summary page for cancer profiles.

NICD1 immunohistochemical staining in normal and tumor tissue.

Histological and immunohistochemical evaluation of primary central nervous system lymphoma. Histological and immunohistochemical evaluation of primary.

SIRT1 is downregulated in human gastric cancer (GC).

The sesquiterpene lactone PN up-regulates MDM2 and p53 proteins.

TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.

Immunohistochemical detection of 8-OHdG by use of the 1F7 monoclonal antibody in oligomer-treated PC3 prostate cancer cells. a, control untreated peripheral.

Activating mutation of Ras is associated with CDCP1 expression in NSCLC. A, NSCLC cell lines with Ras + B-Raf mutations and wild-type Ras were examined.

Immunohistochemical analyses of SHH expression levels in nonmalignant prostate and adenocarcinoma tissues. Immunohistochemical analyses of SHH expression.

Variation in dUTPase expression in cell lines.

E-cadherin synthetic lethal effects operate in vivo in E-cadherin–defective breast tumors. E-cadherin synthetic lethal effects operate in vivo in E-cadherin–defective.

Effect of HA on hematopoietic recovery in tumor-bearing mice.

Antitumor activity of HER2-lytic hybrid peptide in tumor xenograft model in vivo. Antitumor activity of HER2-lytic hybrid peptide in tumor xenograft model.

Expression profile of RSPO1 and 2 in gastric cancer.

Representative examples of estrogen receptor α and β immunohistochemical expression (top figures) and EGFR mutations (bottom figures) in lung adenocarcinomas.

Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,

MAPJD expression in lung cancers.

In vivo thrombosis of tumor vasculature.

A His/Pro-rich fragment of HRG is present in human tissue.

VEGF expression in neoplastic and normal prostate tissue.

Antitumor activity of MLN8237 against TNBC patient-derived tumor xenografts (PDTX) in vivo. Antitumor activity of MLN8237 against TNBC patient-derived.

A, TSG-6 staining in TRAMP tissue and TRAMP cell lines.

Anti-Flk-1 mAb treatment reduces vessel density in tumors.

Cisplatin plus PTUPB decreases proliferation and angiogenesis but increases apoptosis as determined by immunohistochemical (IHC) analysis. Cisplatin plus.

Immunohistochemical detection of nuclear and cytoplasmic YB-1 in osteosarcoma and synovial sarcoma. Immunohistochemical detection of nuclear and cytoplasmic.

SAF-1 expression in clinical breast cancer tissues.

PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. A, 4T1/HAS3.

Endothelial cells/microvasucles are increased in prostate cancer versus normal tissues. Endothelial cells/microvasucles are increased in prostate cancer.

Angiogenesis in tumors formed by cells varying in the expression of CXCR2. Angiogenesis in tumors formed by cells varying in the expression of CXCR2. A,

Curcumin enhances effects of bortezomib to inhibit angiogenesis in multiple myeloma tumor samples. Curcumin enhances effects of bortezomib to inhibit angiogenesis.

GA reduces the growth of Caki-1 tumor xenografts.

Immunohistochemical staining of primary and metastatic prostatic carcinomas with anticyclin D1 and anti-Ki67 monoclonal antibodies. Immunohistochemical.

MET amplification is selected in KRAS wild-type colorectal cancer samples from patients who developed resistance to anti-EGFR treatment. MET amplification.

Tumor and serum levels of murine IL-12.

Binding and antiproliferative effects of ANG4043 and anti-HER2 mAbs on tumor cells. Binding and antiproliferative effects of ANG4043 and anti-HER2 mAbs.

Visualization of tumor vasculature using anti-CD31 immunohistochemistry. Visualization of tumor vasculature using anti-CD31 immunohistochemistry. Micrographs.

Mir-128 reduction in breast cancer tissues correlates chemotherapy resistance and poor patient survival. Mir-128 reduction in breast cancer tissues correlates.

Docking validation of Dud778-dUTPase cocrystal structure.

Ki-67 expression in M31- and H3-treated tumors (A) and respective Ki-67 labeling indices in the two groups of tumors (B). Ki-67 expression in M31- and.

Localization of oxidated thiols in A375 melanoma cells.

PTPH1 depends on its catalytic activity to increase ER nuclear accumulation and to enhance breast cancer sensitivity to TAM. A, effects of PTPH1 and PTPH1/DA.

CRA inhibits the growth of human tumor xenografts in vivo.

Immunohistochemical staining for FOXO3a of breast cancer tumor tissues

Reduced klotho expression in pancreatic cancer.

Expression of versican promoted breast cancer cell tumor formation and self-renewal in vivo. Expression of versican promoted breast cancer cell tumor formation.

In situ analysis of human breast tissue shows the down-regulation of Spry isoforms in breast cancer. In situ analysis of human breast tissue shows the.

Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8 and Stat3+/+:HPV8 mice. Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8.

Progastrin staining in colon adenomas and adenocarcinomas.

Histology (H&E; original magnification, ×100 for B-2P/C-12P/C-64P and ×40 for C-10P; top) of small-sized lung adenocarcinomas and immunohistochemical staining.

Specific reaction with MIB1, M30, and CD31 monoclonal antibodies in primary human cervical carcinoma before (A, C, and E) and after (B, D, and F) Tam treatment.

The CCR5+ population of SUM-159 cells is enriched with tumor-initiating cells. The CCR5+ population of SUM-159 cells is enriched with tumor-initiating.

Reduced expression of the tumor suppressor PTEN occurs in tumors with both squamous cell and adenocarcinoma histology. Reduced expression of the tumor.

Defining the eTME genes.

AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. A,

CD36 expression is coordinately regulated in multiple cellular compartments. CD36 expression is coordinately regulated in multiple cellular compartments.

CD36 expression in tissue adjacent and distal to the tumor.

Expression of the angiogenic phenotype in the 4-NQO mouse model of HNSCC. A, tissue sections containing areas of normal, hyperkeratosis, dysplasia, and.

Comparison of PD-L1 mAbs in IHC across multiple tumor types.

IHC staining of FFPE esophageal tissues in tissue microarrays (×20).

Presentation transcript:

Immunohistochemical analysis of dUTPase in human breast adenocarcinoma. Immunohistochemical analysis of dUTPase in human breast adenocarcinoma. Formalin-fixed, paraffin-embedded breast cancer tumor specimens were routinely processed and stained using the DUT415 monoclonal antibody. A, low dUTPase expression. B and C, elevated nuclear and cytoplasmic expression. Magnification, ×20 (A and B) and ×40 (C). Peter M. Wilson et al. Mol Cancer Ther 2008;7:3029-3037 ©2008 by American Association for Cancer Research